No Data
No Data
Daily Options Recap | NVIDIA options trading surged to 7 million contracts! Bullish bets on call options heating up for a rebound; Major change! Intel now selling tens of millions of dollars in put options.
Affirm Holdings, the American version of "Huabei", soared 32% after its performance report. The volume of options contracts exceeded 0.46 million, more than 4 times the average daily trading volume on the 30th. The call option ratio is 71%.
Optimistic Buy Rating for Edgewise Therapeutics Amid Promising EDG-7500 Developments
Edgewise Therapeutics Price Target Maintained With a $31.00/Share by Wedbush
Wedbush Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $31
Wedbush analyst Laura Chico maintains $Edgewise Therapeutics(EWTX.US)$ with a buy rating, and maintains the target price at $31.According to TipRanks data, the analyst has a success rate of 48.1%
Wedbush Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Insulet (PODD), Recursion Pharmaceuticals (RXRX) and Edgewise Therapeutics (EWTX)